Arvinas (ARVN) EBITDA (2017 - 2026)

Arvinas' EBITDA history runs 10 years deep, the most recent figure standing at -$63.8 million for Q1 2026.

• On a quarterly basis, EBITDA fell 189.36% year-over-year to -$63.8 million in Q1 2026; TTM through Mar 2026 was -$253.7 million, a 165.38% decrease from a year earlier, with the FY2025 full-year figure at -$118.5 million, up 52.64% from the prior year.
• EBITDA climbed to -$63.8 million in Q1 2026 per ARVN's latest filing, from -$74.6 million in the prior quarter.
• Across five years, EBITDA topped out at $71.4 million in Q1 2025 and bottomed at -$165.3 million in Q4 2023.
• The 5-year median for EBITDA is -$65.8 million (2022), against an average of -$64.6 million.
• Across the five-year window, EBITDA jumped 185.71% in 2025 and slumped 189.36% in 2026, its largest moves.
• Year by year, EBITDA stood at -$75.6 million in 2022, then slumped by 118.65% to -$165.3 million in 2023, then soared by 64.79% to -$58.2 million in 2024, then decreased by 28.18% to -$74.6 million in 2025, then advanced by 14.48% to -$63.8 million in 2026.
• Per Business Quant, the three latest ARVN EBITDA figures stand at -$63.8 million (Q1 2026), -$74.6 million (Q4 2025), and -$43.8 million (Q3 2025).